New AI Cell-Analysis System Streamlines Blood Disease Diagnosis
Scientists developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples.
Read MorePosted by Andy Lundin | Aug 10, 2023 | Microscopy |
Scientists developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Unknown Origin & Other Cancer Types |
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read MorePosted by Melanie Hamilton-Basich | Jun 26, 2023 | Unknown Origin & Other Cancer Types |
By testing a range of therapies in organoids grown from the patient’s own tumor sample, SEngine’s PARIS Test identified off-label therapy that proved highly successful for one ovarian cancer patient.
Read MorePosted by Melanie Hamilton-Basich | Jun 14, 2023 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Precipio’s HemeScreen Cytopenia panel enabled a patient’s diagnosis without the need for a painful, invasive bone marrow biopsy.
Read MorePosted by Melanie Hamilton-Basich | Jun 8, 2023 | Cancer, Molecular Diagnostics |
Invivoscribe and Complete Genomics have partnered to develop and commercialize cancer biomarker tests on Complete Genomics’ NGS platforms.
Read More